selected publications
-
academic article
- A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.. International journal of cancer. 144:2192-2205. 2019
- Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.. Cancer research. 79:505-517. 2019
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. 2017
- Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.. British journal of cancer. 116:524-535. 2017
- PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. 53:800-811. 2016
- Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.. International journal of epidemiology. 45:1619-1630. 2016
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.. Nature communications. 7:-. 2016
- Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.. Human genetics. 135:741-756. 2016
- Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.. Genetic epidemiology. :-. 2015
- Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. :-. 2015
- Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.. Human molecular genetics. :-. 2015
- Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study.. Gynecologic oncology. 136:542-548. 2015
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 2015
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. 2015
- The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.. The Journal of infectious diseases. 199:936-944. 2009
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.. Gynecologic oncology. -. 2015